These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 21638520)
21. An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies. Maciá-Martínez MA; de Abajo FJ; Roberts G; Slattery J; Thakrar B; Wisniewski AF Drug Saf; 2016 Jan; 39(1):29-43. PubMed ID: 26507885 [TBL] [Abstract][Full Text] [Related]
22. Comment on: "Adverse drug reaction reporting by patients: an overview of fifty countries". Ahmad SR Drug Saf; 2015 Jan; 38(1):109-10. PubMed ID: 25414075 [No Abstract] [Full Text] [Related]
23. Drug makers' adverse event reports are often incomplete, US report finds. McCarthy M BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561 [No Abstract] [Full Text] [Related]
25. A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases. Arnaud M; Salvo F; Ahmed I; Robinson P; Moore N; Bégaud B; Tubert-Bitter P; Pariente A Drug Saf; 2016 Mar; 39(3):251-60. PubMed ID: 26715499 [TBL] [Abstract][Full Text] [Related]
26. A comparison of disproportionality analysis methods in national adverse drug reaction databases of China. Hou Y; Ye X; Wu G; Cheng G; Du X; He J Expert Opin Drug Saf; 2014 Jul; 13(7):853-7. PubMed ID: 24918197 [TBL] [Abstract][Full Text] [Related]
28. Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification. Osokogu OU; Dodd C; Pacurariu A; Kaguelidou F; Weibel D; Sturkenboom MC Drug Saf; 2016 Sep; 39(9):873-81. PubMed ID: 27255487 [TBL] [Abstract][Full Text] [Related]
29. Aggregation and analysis of indication-symptom relationships for drugs approved in the USA. Punyala A; Lankapalli R; Hindman D; Racz R Eur J Clin Pharmacol; 2020 Sep; 76(9):1291-1299. PubMed ID: 32495081 [TBL] [Abstract][Full Text] [Related]
30. Authors' reply to Ahmad SR: "Adverse drug reaction reporting by patients: an overview of fifty countries". Margraff F; Bertram D Drug Saf; 2015 Jan; 38(1):111. PubMed ID: 25414076 [No Abstract] [Full Text] [Related]
31. Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Abbing-Karahagopian V; Kurz X; de Vries F; van Staa TP; Alvarez Y; Hesse U; Hasford J; Dijk Lv; de Abajo FJ; Weil JG; Grimaldi-Bensouda L; Egberts AC; Reynolds RF; Klungel OH Curr Clin Pharmacol; 2014 May; 9(2):130-8. PubMed ID: 24218995 [TBL] [Abstract][Full Text] [Related]
32. The potential role of big data in the detection of adverse drug reactions. Sultana J; Trifirò G Expert Rev Clin Pharmacol; 2020 Mar; 13(3):201-204. PubMed ID: 32176553 [No Abstract] [Full Text] [Related]
33. A potential competition bias in the detection of safety signals from spontaneous reporting databases. Pariente A; Didailler M; Avillach P; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Moore N Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1166-71. PubMed ID: 20848561 [TBL] [Abstract][Full Text] [Related]
34. Comparison of statistical signal detection methods within and across spontaneous reporting databases. Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605 [TBL] [Abstract][Full Text] [Related]
35. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review. Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712 [TBL] [Abstract][Full Text] [Related]
36. AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System. Grigoriev I; zu Castell W; Tsvetkov P; Antonov AV Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):795-801. PubMed ID: 24677538 [TBL] [Abstract][Full Text] [Related]
37. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database. Kumlien E; Lundberg PO Seizure; 2010 Mar; 19(2):69-73. PubMed ID: 20036167 [TBL] [Abstract][Full Text] [Related]
38. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands. Scholl JH; van Puijenbroek EP Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1361-1367. PubMed ID: 27686554 [TBL] [Abstract][Full Text] [Related]
39. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Holm L; Ekman E; Jorsäter Blomgren K Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):335-343. PubMed ID: 28071845 [TBL] [Abstract][Full Text] [Related]
40. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]